Please use this identifier to cite or link to this item:
Title: Conformational polymorphs of a muscle relaxant, metaxalone
Authors: Aitipamula, S.
Chow, P.S.
Tan, R.B.H. 
Issue Date: 7-Sep-2011
Citation: Aitipamula, S., Chow, P.S., Tan, R.B.H. (2011-09-07). Conformational polymorphs of a muscle relaxant, metaxalone. Crystal Growth and Design 11 (9) : 4101-4109. ScholarBank@NUS Repository.
Abstract: Metaxalone (MTX) is a muscle relaxant which is used to relieve pain caused by strains and sprains. MTX has been in the market under the brand name of Skelaxin since 1962, and two polymorphs of MTX were first mentioned in a patent published in 2007. However, their crystal structures, stability relationship, and dissolution profiles have not yet been analyzed. We herein report two conformational polymorphs of racemic MTX with an objective to unravel the structural origin of polymorphism and study their phase transformations, stability, solubility, and dissolution properties. Both forms were obtained concomitantly by cooling crystallization experiments from ethyl acetate. Crystal structure analysis revealed that the MTX molecule adopts different conformations in the polymorphs. Interestingly, the imide group of the MTX forms an imide-imide catemer synthon in Form A and an imide-imide dimer synthon in Form B. Thermal analysis and solubility measurements suggest an enantiotropic relationship between the polymorphs with Form B being the thermodynamically stable form at ambient conditions. The metastable Form A converts to stable Form B in slurry and solid-state grinding experiments and dissolves faster than the stable Form B at 37 °C. © 2011 American Chemical Society.
Source Title: Crystal Growth and Design
ISSN: 15287483
DOI: 10.1021/cg200678e
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Oct 18, 2018


checked on Oct 10, 2018

Page view(s)

checked on Oct 20, 2018

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.